[Duration of adjuvant treatment with tamoxifen in patients with resectable breast cancer]
Tamoxifen administered in patients after breast cancer surgery is one of the most effective adjuvant treatments in this pathology. A large number of randomized studies including thousands of patients allowed to quantify the treatment benefits in terms of recurrence, contralateral breast cancer and o...
Hauptverfasser: | Davies, C, Arriagada, R, Ziegler, A, Peralta, O |
---|---|
Format: | Journal article |
Sprache: | Spanish; Castilian |
Veröffentlicht: |
1998
|
Ähnliche Einträge
Ähnliche Einträge
-
[Adjuvant tamoxifen duration: more large-scale randomized evidence is needed]
von: Davies, C, et al.
Veröffentlicht: (1997) -
Variation in use of adjuvant tamoxifen.
von: Davies, C, et al.
Veröffentlicht: (1998) -
Adjuvant treatment with tamoxifen. Recruitment into studies assessing optimum duration of treatment must continue.
von: Earl, H, et al.
Veröffentlicht: (1996) -
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
von: Gelber, R, et al.
Veröffentlicht: (1996) -
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
von: Dowsett, M, et al.
Veröffentlicht: (2009)